关注症状性颅内动脉狭窄.pptVIP

下载本文档

7
0
约8.31千字
约 32页
2019-05-27 发布于江西
举报
版权申诉

关注症状性颅内动脉狭窄.ppt

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

缺血性脑血管病患者脑动脉狭窄特征 527例国内脑梗死/TIA (2004-2005) DSA:主动脉弓+锁骨下动脉+全脑好发部位：颅内-MCA, ICA颅内段; 颅外-ICA/VA起始部中年(41-60岁)和老年(60岁)以合并颅内外动脉狭窄为最高美国AHA神经介入指南对颅内动脉狭窄的缺血性卒中二级预防高级别推荐抗栓治疗谢谢 * * WASID研究的结论：在症状性IAS 患者中狭窄程度严重者、事件发生在17 天内者是复发性狭窄动脉区域缺血性卒中的独立预测因素，女性和入组时NIHSS＞1 分的患者也是复发性狭窄动脉区域缺血性卒中的高危人群，其中严重狭窄是最强的预测因素；而以往回顾性研究认为与复发性狭窄动脉区域缺血性卒中的危险有关联的2 个因素，即病变位于后循环（椎基底动脉）和抗栓治疗失败，在这个设计和实施严格的前瞻研究中未得到证实。 Background—Antithrombotic therapy for intracranial arterial stenosis was recently evaluated in the Warfarin versus Aspirin for Symptomatic Intracranial Disease (WASID) trial. A prespecified aim of WASID was to identify patients at highest risk for stroke in the territory of the stenotic artery who would be the target group for a subsequent trial comparing intracranial stenting with medical therapy. Methods and Results—WASID was a randomized, double-blinded, multicenter trial involving 569 patients with transient ischemic attack or ischemic stroke due to 50% to 99% stenosis of a major intracranial artery. Median time from qualifying event to randomization was 17 days, and mean follow-up was 1.8 years. Multivariable Cox proportional hazards models were used to identify factors associated with subsequent ischemic stroke in the territory of the stenotic artery. Subsequent ischemic stroke occurred in 106 patients (19.0%); 77 (73%) of these strokes were in the territory of the stenotic artery. Risk of stroke in the territory of the stenotic artery was highest with severe stenosis 70% (hazard ratio 2.03; 95% confidence interval 1.29 to 3.22; P0.0025) and in patients enrolled early (17 days) after the qualifying event (hazard ratio 1.69; 95% confidence interval 1.06 to 2.72; P0.028). Women were also at increased risk, although this was of borderline significance (hazard ratio 1.59; 95% confidence interval 1.00 to 2.55; P0.051). Location of stenosis, type of qualifying event, and prior use of antithrombotic medications were not associated with increased risk. Conclusions—Among patients with symptomati